Pharma feed

N
Bayer AG
Youtube· 21 Jun 2021

Making, measuring, and maintaining a sustainable company

AboutPressCopyrightContact usCreatorsAdvertiseDevelopersTermsPrivacyPolicy & SafetyHow YouTube worksTest new features

  • Bayer AG
  • ESG
  • Videos
  • Social Media
N
Pfizer Inc
PR Newswire· 21 Jun 2021

Disruptive Floss Upgrade Provides Licensing Opportunity

AwesomeFloss.com's founder Leonard Lorch announced today that on June 10, 2021 he transmitted an invitation to Pfizer Inc's CEO Albert Bourla on Lorch's patented dental floss upgrade called the Awesome Floss® upgrade for Pfizer's joint venture with GSK pursuant to its JV's consumer products.

  • Pfizer Inc
  • Partnerships and Alliances
  • Press Releases
  • Press Release Agencies
N
Pfizer Inc
The Guardian· 21 Jun 2021

Coronavirus live news: US delays easing of land border restrictions; Japan to rule on allowing fans at Olympics

Reports suggest Tokyo 2020 organisers will allow 10,000 fans; New Zealand approves Pfizer vaccine for 12-15 year olds; US borders with Canada and Mexico to remain closed to non-essential travel until 21 July

  • Pfizer Inc
  • Regulatory and Legal
  • News Articles
  • News Websites
Novartis AG
Novartis AG· 21 Jun 2021

Discover how inflammation could fan the flames of cancer

Targeting inflammation to fight cancer is a new approach with a long history. Your body has a built-in sensor that self-assembles inside cells in response to a threat. This danger-sensing system is a large piece of cellular machinery, but until 20 years ago, no one knew it existed.

  • Novartis AG
  • New Offerings
  • Press Releases
  • Company Websites
Johnson & Johnson
Johnson & Johnson· 21 Jun 2021

Ethicon Expands Advanced Biopolar Energy Portfolio With Launch Of Enseal X1 Curved Jaw Tissue Sealer

Innovation CINCINNATI, OH – June 21, 2021 -- Ethicon*, part of the Johnson & Johnson Medical Devices Companies,** today announced the launch of the ENSEAL X1 Curved Jaw Tissue Sealer, a new advanced bipolar energy device that increases procedural efficiency[1] and provided stronger sealing[2] and better access to more tissue than LigaSure™ Maryland.[3] The device is indicated for colorectal, gynecological, bariatric surgery and thoracic procedures.

  • Johnson & Johnson
  • Johnson & Johnson Medical
  • New Offerings
  • ESG
  • Press Releases
  • Company Websites
N
Johnson & Johnson
Dakota Financial News· 21 Jun 2021

OmniStar Financial Group Inc. Has $761,000 Stake in Johnson & Johnson (NYSE:JNJ)

OmniStar Financial Group Inc. decreased its position in Johnson & Johnson (NYSE:JNJ) by 37.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,633 shares of the company’s stock after selling 2,831 shares during the quarter.

  • Johnson & Johnson
  • M&A Activities
  • Financial Results
  • News Articles
  • News Websites
N
GlaxoSmithKline PLC
Business Insider· 21 Jun 2021

5 burning questions facing pharma giant GlaxoSmithKline and CEO Emma Walmsley before a crucial investor day

Leaders of GlaxoSmithKline will present their vision for the pharma giant on Wednesday. GSK has faced mounting questions over its vaccine business and cancer-research strategy. We're watching for five pressing questions that GSK may attempt to answer.

  • GlaxoSmithKline PLC
  • Events
  • News Articles
  • News Websites
N
Pfizer Inc
Nasdaq· 21 Jun 2021

Pfizer Vaccine Approved for 12-15-Year Olds in New Zealand – Report

“After careful consideration of the most up-to-date scientific and medical data available, Medsafe has announced provisional approval for our young people to be given the Pfizer vaccine,” Reuters quoted PM Jacinda Ardern as saying. Medsafe is New Zealand’s drugs regulator.

  • Pfizer Inc
  • Regulatory and Legal
  • News Articles
  • Stock Exchanges
Bayer AG
Agrospectrumindia· 21 Jun 2021

Bayer launches yellow watermelon variety in India

Bayer launches yellow watermelon variety in India Yellow Gold 48 has a thicker rind compared to the red watermelon variety, enabling a longer shelf-life and reducing potential losses from damage during transportation from farms to markets Bayer has launched a yellow watermelon variety in the Indian market and is known as ‘Yellow Gold 48,’ under its Seminis brand of high-yielding vegetable seeds.

  • Bayer AG
  • New Offerings
  • News Articles
  • Company Websites
N
Sanofi
Nasdaq· 21 Jun 2021

Sanofi's (SNY) Aubagio Gets EU Nod for MS in Pediatric Patients

Sanofi SNY announced that the European Commission has approved Aubagio (teriflunomide) for the treatment of relapsing-remitting multiple sclerosis (“RRMS”) in pediatric patients aged 10 to 17 years. Following the nod, Aubagio became the first oral multiple sclerosis (“MS”) therapy to be approved in Europe for the first-line treatment of children and adolescents with MS.

  • Sanofi
  • Regulatory and Legal
  • News Articles
  • Stock Exchanges
Cadila Healthcare Ltd
Zyduscadila· 21 Jun 2021

Zydus and Bayer announce continuity of their successful Joint Venture

This insight has a PDF attached. Please click on the headline to view the PDF in a new tab

  • Cadila Healthcare Ltd
  • Bayer AG
  • Partnerships and Alliances
  • Press Releases
  • Company Websites
N
Pfizer Inc
Philippine Canadian Inquirer· 21 Jun 2021

Gov’t to use half of 40M Pfizer shots to children ages 12 to 15

Pfizer and the government signed on Saturday a supply agreement for 40 million doses of vaccines to be delivered by the third and fourth quarter of 2021. (File photo by Marco Verch Professional Photographer/Flickr, CC BY 2.0) MANILA – Half of the 40 million Pfizer-BioNTech vaccines that the Philippine government secured will be used for children under the 12 to 15 age bracket, vaccine czar and National Task Force against Covid-19 chief implementer Secretary Carlito Galvez Jr.

  • Pfizer Inc
  • Procurement and Sales
  • News Articles
  • News Websites
N
BIOS, LLC
The Business Journals· 21 Jun 2021

The Petri Dish: BIO's diversity numbers, Exelixis' CMO takes medical leave

Please Sign In and use this article's on page print button to print this article.

  • BIOS, LLC
  • Exelixis Inc
  • ESG
  • News Articles
  • News Websites
N
Pfizer Inc
The New Indian Express· 21 Jun 2021

Philippines set to buy 40 million doses of Pfizer COVID-19 vaccine

MANILA: The Philippine government has signed a purchase deal for 40 million doses of Pfizer COVID-19 vaccine in its largest such agreement this year after huge demands from wealthy countries started to ease. Carlito Galvez Jr., who oversees the government's vaccine purchases, said bulk shipments funded by loans from the Asian Development Bank and other lenders will start in August.

  • Pfizer Inc
  • Procurement and Sales
  • News Articles
  • News Websites
N
Pfizer Inc
Sltrib· 21 Jun 2021

On a slow Sunday, the percentage of positive COVID-19 cases falls a bit below 7-day averages

(Francisco Kjolseth | The Salt Lake Tribune) Moderna doses are ready to go alongside Pfizer doses for 12-15 year olds beginning to get their vaccinations against COVID-19 at the Mountain America Expo Center in Sandy on Tuesday, May 18, 2021.

  • Pfizer Inc
  • Events
  • News Articles
  • News Websites
N
Takeda Pharmaceutical Co Ltd
Seymour Telegraph· 21 Jun 2021

School holiday fun in Mitchell Shire

On the eve of another school holidays with restrictions on travel and socialising, Mitchell Shire Council has a number of small group and online activities to help keep young minds entertained. Budding artists aged 12 to 24 are invited to take part in a youth graffiti workshop as part of Youth Week, which falls in the first half of the school holidays.

  • Takeda Pharmaceutical Co Ltd
  • Events
  • News Articles
  • News Websites
N
Sanofi
Jd Supra· 21 Jun 2021

Pensions UK: What's new this week - June 2021 #4

Welcome to your weekly update from the Allen & Overy Pensions team, covering all the latest legal and regulatory developments in the world of occupational pensions. This week we cover topics including: TPR reports on regulatory intervention with Sanofi; and HMRC challenges tax avoidance arrangements using unfunded pension obligations.

  • Sanofi
  • Regulatory and Legal
  • News Articles
  • News Websites
N
Johnson & Johnson
Sowetan Live· 21 Jun 2021

President Cyril Ramaphosa defends SA's use of J&J vaccine

President Cyril Ramaphosa has defended his government's insistence on going ahead with plans to roll out the Johnson & Johnson (J&J) vaccine. Speaking at the opening session of the Qatar Economic Forum, Ramaphosa said SA would be going ahead with its vaccination programme using the J&J vaccine.

  • Johnson & Johnson
  • Events
  • News Articles
  • News Websites
N
AstraZeneca PLC
Advisory· 21 Jun 2021

Around the nation: Federal judge refuses request to dismiss 340B lawsuit

U.S. District Judge Leonard Stark on Wednesday denied HHS' request to dismiss a lawsuit from AstraZeneca challenging an advisory opinion that prevents drugmakers from restricting sales to contract pharmacies under the 340B program, in today's bite-sized hospital and health industry news from California, Delaware, and Georgia.

  • AstraZeneca PLC
  • Regulatory and Legal
  • Negative News
  • News Articles
  • News Websites
Gilead Sciences, Inc.
Gilead· 21 Jun 2021

Gilead to Present More Than 70 Abstracts From Diverse Liver Disease Programs At The International Liver Congress™ 2021

June 21, 2021 FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that more than 70 abstracts from the company’s liver disease programs will be presented at The International Liver Congress ™ 2021 (ILC) taking place from June 23-26.

  • Gilead Sciences, Inc.
  • Events
  • Press Releases
  • Company Websites
N
Unimed
Law 360· 21 Jun 2021

High Court Won't Hear Sham Litigation Exception Case

Law360 (June 21, 2021, 11:08 AM EDT) -- The U.S. Supreme Court won't review a Third Circuit ruling that AbbVie delayed generic versions of its testosterone treatment AndroGel through sham litigation. The high court on Monday shot down a petition from AbbVie, Abbott Laboratories, Unimed Pharmaceuticals LLC and Besins Healthcare, which argued that the Third Circuit's decision "effectively nullifies" the subjective prong of the Noerr-Pennington doctrine's "sham litigation" exception.

  • Unimed
  • Besins Healthcare Luxembourg SARL
  • AbbVie Inc
  • Regulatory and Legal
  • Negative News
  • News Articles
  • News Websites
Bayer AG
Bayer AG· 21 Jun 2021

Bayer submits regulatory applications for oncology treatment combination of copanlisib and rituximab in the U.S. and EU

About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population.

  • Bayer AG
  • New Offerings
  • Regulatory and Legal
  • Press Releases
  • Company Websites
N
US Food and Drug Administration
Targeted Oncology· 21 Jun 2021

FDA Approval Sought for Copanlisib Plus Rituximab in Relapsed iNHL

A supplemental new drug application has been submitted to the FDA seeking approval for the combination of copanlisib (Aliqopa) and rituximab (Rituxan) for the treatment of relapsed indolent B-cell non-Hodgkin’s Lymphoma (iNHL) and is outside of the FDA accelerated approved indication for the treatment of relapsed follicular lymphoma who have received at least 2 prior systemic therapies, according to a press release by Bayer AG.

  • US Food and Drug Administration
  • Bayer AG
  • Regulatory and Legal
  • News Articles
  • News Websites
N
GlaxoSmithKline PLC
Investorschronicle· 21 Jun 2021

Judgment day looming for GSK

Management is expected to run through growth projections, a mooted dividend cut and what the plans are for the consumer business Activist investor Elliott has built a significant stake in the group The pressure is on for GlaxoSmithKline (GSK) as its investor day on 23 June draws ever closer.

  • GlaxoSmithKline PLC
  • M&A Activities
  • News Articles
  • News Websites
N
Bayer AG
Geneticliteracyproject· 21 Jun 2021

Glyphosate does not cause cancer, latest independent European Union study concludes

Despite the allegations of greedy trial lawyers and greedy, ideological activist groups, a massive body of peer-reviewed research has confirmed that glyphosate, the active ingredient in Bayer’s Roundup weed killer, poses minimal risk to human health and the environment.

  • European Union
  • Bayer AG
  • Regulatory and Legal
  • ESG
  • News Articles
  • News Websites
1 2 3 4 5